NCT07732257 Wireless MicroPremVitals Button Sensor in the NICU
| NCT ID | NCT07732257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Condition | Premature Birth |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-06-19 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2026-06-19 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A wireless and miniaturized vital sign (ECG, SpO2, Skin Temperature) sensor system, MicroPremVitals Button Sensors was developed by the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) to facilitate vital sign monitoring in extremely preterm neonates.
Eligibility Criteria
Inclusion Criteria: * Infants admitted to the NICU with a gestational age of ≥ 22+0 weeks and ≤ 29+6 weeks at birth, * AND \>72h of age at time of study, * AND clinically stable, * AND with the Neonatal Nurse Practitioner (i.e., NNP) and Healthcare Team in agreement for the patient to participate in the study. Exclusion Criteria: * Infants with a skin abnormality that would potentially increase the risk of injury, * patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment. * Infants admitted to the NICU with a gestational age of \< 22+0 weeks or \> 29+6 weeks at birth, * and/or ≤ 72h of age at time of study, * and/or not meeting all requirements of clinical stability, * and/or with the Neonatal Nurse Practitioner (i.e., NNP)/Healthcare Team in disagreement for the patient to participate in the study.
Contact & Investigator
Guilherme Sant'Anna, MD, PhD
PRINCIPAL INVESTIGATOR
The Research Institute of the McGill University Health Center
Frequently Asked Questions
Who can join the NCT07732257 clinical trial?
This trial is open to participants of all sexes, studying Premature Birth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07732257 currently recruiting?
Yes, NCT07732257 is actively recruiting participants. Contact the research team at alyssa.maximov@muhc.mcgill.ca for enrollment information.
Where is the NCT07732257 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT07732257 clinical trial?
NCT07732257 is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. The principal investigator is Guilherme Sant'Anna, MD, PhD at The Research Institute of the McGill University Health Center. The trial plans to enroll 10 participants.